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ABSTRACT: Signal ampliﬁcation by reversible exchange (SABRE) is an inexpensive, fast, and even continuous
hyperpolarization technique that uses para-hydrogen as hyperpolarization source. However, current SABRE faces a number
of stumbling blocks for translation to biochemical and clinical settings. Diﬃculties include ineﬃcient polarization in water,
relatively short-lived 1H-polarization, and relatively limited substrate scope. Here we use a water-soluble polarization transfer
catalyst to hyperpolarize nitrogen-15 in a variety of molecules with SABRE-SHEATH (SABRE in shield enables alignment
transfer to heteronuclei). This strategy works in pure H2O or D2O solutions, on substrates that could not be hyperpolarized in
traditional 1H-SABRE experiments, and we record 15N T1 relaxation times of up to 2 min.
■ INTRODUCTION
NMR and MRI are nondestructive methods to obtain
information about molecular structure and spatial morphology.
However, magnetic resonance is restricted mainly by the
inherently low sensitivity as a result of low thermal polarization
levels. For example, NMR spectroscopy and clinical MRI
predominantly use highly abundant 1H nuclei. Even so,
observation of low concentration analytes remains challenging.
Hyperpolarization methods (e.g., DNP, PHIP, SABRE,
SEOP)1−7 enhance MR signals by 4−5 orders of magnitude
and overcome inherent sensitivity limitations.9−12
Traditionally, hyperpolarization methods require extensive
optimization. Usually methods and optimization are associated
with high experimental complexity and cost. In this regard,
signal ampliﬁcation by reversible exchange (SABRE) stands out
because it is simple, fast, and continuously repeatable.4,13
SABRE uses readily available para-hydrogen (p-H2) as a source
of polarization. The transfer occurs in reversibly formed
substrate−hydrogen adducts in a transition metal complex.
The magnetic evolution ﬁeld Bevo must be suﬃciently low to
mix energy levels between hydride-1H and the target nucleus to
establish a path for polarization transfer.7,14 While protons in
the substrate are targeted at magnetic ﬁelds around 65 G,15
transfer to heteronuclei (e.g., 15N, 13C, 31P) occurs at μT
magnetic ﬁelds using a technique termed SABRE in shield
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enables alignment transfer to heteronuclei (SABRE-
SHEATH).7,8 As shown in Scheme 1, the required hardware
is relatively simple.
As a result of experimental simplicity and its promise, SABRE
and SABRE-SHEATH are now attracting an increasing number
of research groups contributing to its rapid develop-
ment.4,7,15−21 A milestone for SABRE was the transition from
organic solvents to aqueous solutions, which was recently
achieved for 1H-SABRE.22−28
Still, for 1H spin−lattice relaxation times are relatively short
and the substrate scope is limited. Direct polarization transfer
to heteronuclei has not been demonstrated in an aqueous
environment. Hyperpolarizing nitrogen-15 via SABRE-
SHEATH allows a wider range of structural motifs, and
relaxation times are characteristically larger.
SABRE-SHEATH with 15N targets is made accessible with
the water-soluble [IrCl(IDEG)(COD)] precatalyst (1a). As
shown in Scheme 2 the precatalyst is converted to the
catalytically active species (1) in the presence of substrates
under a hydrogen atmosphere.22 At μT magnetic ﬁeld hydride
and 15N energy levels match and the spin system coherently
evolves with a rate given by JNH- into
15N-polarization on
substrates.29
We investigate diﬀerent molecular motifs found in medical
drugs, biomolecules, and molecular tags. Structural motifs could
be readily translated from the established [IrCl(IMes)(COD)]
system.16,30
Pyridine (2), the canonical SABRE substrate,4 was a logical
ﬁrst choice. Next, nitriles are often encountered in drugs,31
polarize consistently well, tolerate complex backbones, and
show large 15N-SABRE-SHEATH enhancements, despite little
to no 1H-SABRE enhancements.30,32 We selected benzonitrile
(3) and α-cyano-4-hydroxycinnamic acid (4) (CHCA, buﬀered
with NaOD to pH 7.5). Diazirines, which also do not exhibit
1H enhancements, are common biomolecular tags that can
replace CH2 groups in many classes of biomolecules.
33 Here we
use 2-cyano-3-(D3-methyl-
15N2-diazirine)propanoic acid (5).
Lastly, we focus on nicotinamide (6), the amide of vitamin B3,
which could be tolerated in vivo at detectable concentra-
tions34−36 and is a potential option for translation to biomedical
studies.20,37
For these substrates we detail hyperpolarization levels,
carefully characterize temperature and magnetic ﬁeld depend-
encies, consider the eﬀect of deuterated vs protonated solvents
(D2O vs H2O), and measure relaxation time constants at
various magnetic ﬁelds.
■ RESULTS AND DISCUSSION
In Figure 1 we show a comparison between single-scan spectra
originating from compounds directly SABRE-SHEATH hyper-
polarized in aqueous medium, referenced to thermally polarized
neat 15N-pyridine at 8.45 T. Concentrations of investigated
compounds are diﬀerent as a result of solubility as well as
sample loss phenomena for benzonitrile and pyridine. Both
pyridine and benzonitrile were initially prepared as 100 mM
solutions, but after activation by H2 bubbling the concen-
trations were signiﬁcantly reduced.
A synopsis of experimental results and conditions is given in
Table 1 (experimental details provided in Materials and
Methods). Spectra are acquired at 1 T and 8.45 T (see
Scheme 1) to study the ﬁeld dependence of T1 relaxation as
detailed below. The 1 T measurements also demonstrate the
feasibility of high-sensitivity single-scan 15N detection with a
benchtop NMR system. Furthermore, to determine the eﬀect of
proton-containing solvents, nicotinamide was investigated in
H2O.
We ﬁnd that polarization levels in deuterated solvents are
largely independent of the detection ﬁeld; that is, enhance-
ments simply scale with the thermal polarization. In contrast,
for nicotinamide in H2O (Table 1, entry 6), we observe lower
apparent polarization levels at 8.45 T. This is caused by
relaxation losses during transfer because it takes much longer to
transfer the sample into the high-ﬁeld magnet (∼8 s) than into
the benchtop device sitting right next to the magnetic shields
(∼2 s). The solvent protons (and deuterons) are in chemical
exchange with the 15N-substrate, where they cause spin−dipole
Scheme 1. A sample is hyperpolarized via SABRE-SHEATH
for an evolution time tevo at optimized matching ﬁeld Bevo of
∼0.5 μT established by a small solenoid coil in a magnetic
shield that attenuates the Earth’s magnetic ﬁeld and
transferred into a Benchtop (1 T) NMR spectrometer or
conventional high-ﬁeld (8.45 T) spectrometer for detection.
Scheme 2. Precatalyst [IrCl(IDEG)(COD)] (1a) is
transformed into the active species [Ir(IDEG)(H)2Sub3]
(Sub = Substrate) (1) in presence of a substrate of choice
(2−6) under a hydrogen atmosphere; reversible exchange
leads to polarization buildup on 15N within 30−120 s; the
polarization transfer is primarily driven by the N−H
coupling through the bonds that form a 180° angle as the
N−H coupling through bonds forming a 90° angle is close to
zero.
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relaxation. This relaxation mechanism scales with the distance
between the relaxation partners rij
−6 as well as the gyromagnetic
ratio, which is 6.5 times smaller for deuterium,38,39 explaining
the observed diﬀerences between solvents.
SABRE-SHEATH in water gives rise to a new set of
challenges. Water has signiﬁcantly higher viscosity and surface
tension than methanol, and at room temperature the solubility
of hydrogen in water is 5 times lower.40,41 We observed that
some samples, speciﬁcally nonpolar liquid-state substrates (e.g.,
benzonitrile and pyridine), are extracted from the solvent when
bubbling with hydrogen during the polarization buildup.
Nicotinamide and CHCA, both crystalline solids when isolated,
were used for systematic studies, as substrate loss did not
occur.20
Of particular interest are the dependence of the 15N
polarization on temperature and magnetic evolution ﬁeld Bevo.
Figure 2 contrasts the established [IrCl(IMes)(COD)] in
methanol and catalyst 1 in H2O/D2O as a function of these
variables (T, Bevo).
The temperature dependence was studied using a 100 mM
nicotinamide sample. For catalyst system 1 in H2O (Figure 2A)
and D2O (Figure 2B) the
15N polarization increases with
temperature. In contrast, in methanol (Figure 2C, [IrCl(IMes)-
(COD)] precursor) the largest polarization is recorded at room
temperature.
The magnetic ﬁeld dependence is shown in Figure 2D. We
compare normalized data (max. 15N polarization: 0.13% in
D2O, 1.7% in MeOH-d4) of two nitrile/solvent systems: ﬁrst, in
blue, 15N-acetonitrile in MeOH-d4 with [IrCl(IMes)(COD)]
and second, in magenta, 15N-CHCA in D2O with [IrCl-
(IDEG)(COD)] (1a).
We note that nitriles are better suited for this study than
nicotinamide, as enhancements are more robust and reprodu-
cible. Additionally, they exhibit inversion of the NMR signal
upon inversion of Bevo. Variation of the temperature changes
the dissociation rate constants of substrate and catalyst-bound
H2.
14,16,42 Optimal polarization transfer eﬃciency is expected
when the exchange rate kdiss is on the order of the
15N to
hydride JNH-coupling across the iridium center (see Scheme
2).14,42 Figure 1A−C show that the IMes catalyst in methanol
yields the largest 15N polarization at room temperature,
Figure 1. 15N spectra of (A) thermally polarized reference at 8.45 T
and (B−F) hyperpolarized compounds (in D2O unless denoted
otherwise). (A) Neat 15N-pyridine, (B) 15N-pyridine, (C) 15N-
benzonitrile, (D) 15N-CHCA, (E) 15N2-diazirine, (F)
15N-nicotina-
mide (in H2O).
Table 1. Synopsis of Experimental Conditions, Enhancements, and Polarization Levelsa
substrate
activation time
[h]
csubstrate/
ccatalyst
cSubstrate
[mM]
enhancement 8.45 T (P
[%])
enhancement 1 T (P
[%])
enhancement ratio (1 T/
8.45 T)
(2) pyridine 12 3.3 16.5c 1100 d d
(3) benzonitrile 0.25 20 50b,c 90 d d
(4) CHCA 12 10 50 440 (0.13) 3700 (0.13) 8.4
(5) diazirine 6 10 16.3 560 (0.16) 4700 (0.17) 8.4
(6) nicotinamide 12 20 100 520 (0.16) 6100 (0.21) 8.9
(6) nicotinamide H2O 12 20 100 630 (0.2) 10 500 (0.37) 28
aSubstrates are 15N labeled, solvent is D2O unless otherwise speciﬁed. Concentrations of liquid substrates are determined at the time of the
experiment using 1H spectroscopy. T = 75 °C. bSignal maximum obtained 30 min after activation, subsequent substrate loss due to evaporation.
cInitial concentration 100 mM. dInsuﬃcient S/N ratio.
Figure 2. Comparison of 15N polarization as a function of temperature
in (A) H2O, (B) D2O, and (C) methanol-d4 at Bevo = 0.5 μT. (D)
Hyperpolarized signals as a function of μT ﬁeld at the temperature
corresponding to the maximum polarization in the respective solvents:
22 °C for 15N-acetonitrile in methanol-d4 and 72 °C for
15N-CHCA in
D2O (blue: 5 mM [IrCl(IMes)(COD)], 30 mM pyridine, 100 mM
15N-CH3CN, methanol-d4; magenta: 5 mM [IrCl(IDEG)(COD)], 30
mM pyridine, 50 mM 15N-CHCA, D2O).
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whereas catalyst 1 requires signiﬁcantly elevated temperatures
to achieve comparable exchange rates leading to maximum
polarization. On the basis of these insights it is reasonable to
expect 15N polarization in water to decrease at even higher
temperatures, in analogy to methanol, as shown in Figure 2C.
As seen in Figure 2D, the methanol and water systems show
very similar responses to Bevo at their respective optimized
temperatures (22 and 72 °C). The response curves originate
from two distinct matching conditions associated with
overpopulation in 15N-α or 15N-β, giving either positive or
negative NMR signal with identical polarization levels.30 The
matching conditions are given by7
γ γ
= ±
+
−
B
J J /2
evo
HH NH
H N (1)
where JHH is the hydride to hydride J-coupling (∼10 Hz) and
JNH the hydride to
15N coupling (∼20 Hz) in 1. Experimentally,
we observe maxima at Bevo ≈ ±0.5 μT, which is slightly higher
than the ±0.3 μT predicted from eq 1, as the limited lifetime
broadens the matching conditions.
Taken together, the observations of Figure 1A−D suggest
that the activation energy of substrate dissociation from 1 is
signiﬁcantly larger than for the established [IrCl(IMes)-
(COD)]−methanol systems. This is also supported by the
fact that catalyst 1 in methanol at RT did not yield any
enhancement.
The absolute polarization level in D2O is about one order of
magnitude smaller than for the methanol system, when
compared at their respective optimized temperatures (15N-
CHCA in D2O, P(
15N) = 0.13%, 15N-CH3CN in d4-MeOH,
P(15N) = 1.7%). Interestingly, this diﬀerence in hyper-
polarization level can simply be attributed to the diﬀerence in
hydrogen solubility (factor 5) and the diﬀerence in solvent
concentration (c(H2O) = 55 mol/L, c(MeOH) = 28 mol/L,
factor 2).
Current experimental data and theoretical considerations
indicate that SABRE polarization levels are limited by the
exchange of hydrides on the iridium center and the exchange
kinetics of other ligand types (substrate/solvent), as well as
both pressure and ﬂow rate of para-hydrogen. Exchange of
hydrogen restores the polarization source to the active complex
species and the process proceeds via the mixed classical/
nonclassical hydride [Ir(H)2(η-H2)(IMes)L2], with arbitrary
ligands L.14,16 Formation of this species requires collision
between a 16-electron complex and a hydrogen molecule,
where collision with a para-hydrogen molecule may refresh the
active species. As a result, the polarization is proportional to the
concentration of para-hydrogen in solution, not the saturation
concentration of hydrogen (ortho + para). Accordingly, the
pressure dependence of polarizations is relatively weak, whereas
dependence on the ﬂow rate is signiﬁcant. Depending on
system composition, a linear or exponential dependence of 15N
polarization on the ﬂow rate was reported.30,43,44 We conclude
that the para-hydrogen enrichment in solution is limited by the
exchange at the gas−liquid interface.
Let us now consider the substrate exchange process. The
rates of ligand dissociation kdiss and association kasso determine
not only the lifetime of the complex, where polarization transfer
from the hydrides to the target nuclei occurs, but also the
concentration of the 16-electron species required for the
hydride exchange.14 As a result 15N polarization depends
directly on the concentration of the 16-electron species.
Accordingly, the largest polarizations are observed at relatively
low catalyst concentrations and high catalyst loadings. It is
noteworthy that an exponential dependence of polarization on
the substrate concentrations has been observed by Appleby et
al.45
We point out that all reported polarization levels are not
optimized with respect to sample composition, concentrations,
hydrogen pressure, or ﬂow rate. Optimization of catalyst
concentration and loading aﬀorded an 8−10-fold increase of
15N polarization level for the methanol system. Maximum
polarizations are recorded at low catalyst concentrations and
high catalyst loadings (15N-nicotinamide P(15N) = 7%,
15N-benzonitrile P(15N) = 16%, metronidazole at natural
abundance P(15N) = 20%).7,14,18,43,46 We conclude that 15N
polarization can be increased by at least a factor 10 by using low
substrate concentrations and high catalyst loading. Further
improvements are expected by modiﬁcations to the exper-
imental setup to allow for more eﬀective mixing of hydrogen
and solvent at higher pressures.
15N Relaxation Times in Water. Of particular importance
for hyperpolarization applications is the spin−lattice relaxation
time T1, which deﬁnes the viable time delay between
preparation of hyperpolarization and detection. We examined
the T1 lifetime for
15N-nicotinamide46 and 15N-CHCA, which
constitute biocompatible compounds and contain 15N in
chemically diﬀerent environments.46−48 Table 2 shows the
15N T1 relaxation times in D2O, which at 1 T exceed 1 min for
both compounds.
For 15N-nicotinamide at 8.45 T we ﬁnd the eﬀect of proton-
containing solvent (H2O) on the T1 time to be negligible. It
should be noted that the 15N T1 time of nicotinamide at 8.45 T
and room temperature is close to the T1 reported for
13C in the
13C(1)-pyruvate markers currently in clinical use for prostate
cancer diagnostics (T1 = 29.2 s in vivo, T1 = 60 s, ex vivo,
3 T).9,10 It is noteworthy that the 13C T1 values in vivo are
smaller than those ex vivo, characteristic for diﬀusion in
constricted environments.
To elucidate this ﬁeld dependence in more detail, we
hyperpolarized 15N-CHCA and held the sample at diﬀerent
ﬁelds for variable times prior to detection. The results are
shown in Figure 3, displaying 15N-relaxation time of CHCA
(50 mM, pH 7.5, D2O) at diﬀerent magnetic ﬁelds. For this
compound relatively low magnetic ﬁelds of about 0.2 T give the
longest relaxation times. This is an intriguing ﬁnding in the
context of low-ﬁeld approaches to NMR and MRI,49,50 which
could be coupled with SABRE to establish low-cost spectros-
copy and molecular imaging.
The scaling of signal-to-noise with magnetic ﬁeld strongly
depends on the exact experimental conditions. For traditional
thermal NMR, the signal is proportional to polarization and the
induction. Both terms are proportional to B0; thus the signal
scales with B0
2.38,51 In NMR, coil noise is typically dominant,
Table 2. 15N T1 Times of 100 mM Nicotinamide and 50 mM
CHCA in D2O at Diﬀerent Detection Fields
T1 [s] 1 T T1 [s] 8.45 T
15N-CHCA 71 ± 15a 24 ± 3
15N-nicotinamide 116 ± 10 32b ± 4
aDetected and stored at 1 T. Control by detection at 8.45 T: T1 = 68
± 2 s. bIn H2O: 32 ± 5.5 s.
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which scales as B0
1/4; hence signal-to-noise (S/N) is propor-
tional to B0
7/4.51−53 However, with a hyperpolarized sample
spin polarization is independent of B0 and, thus, S/N scales
with B0
3/4.
Another scenario arises for human MRI. Here, dielectric
losses dominate, which are proportional to B0. Thus, S/N only
increases proportional to B0 for thermal MRI experiments.
52,54
Therefore, S/N is expected to be independent of B0 for
hyperpolarized human MRI.55,56 MRI in low magnetic ﬁelds
has signiﬁcant advantages, as magnet and RF-circuit design are
ﬂexible, easy to construct, and relatively inexpensive.56,57 For
example, high-performance 1H-MRI at 6.5 mT with thermal
magnetization has already been reported.49 It is noteworthy
that recent advances in the low-ﬁeld domain, such as “external
high-quality-factor-enhanced NMR” (EHQE-NMR)58 and
others,59 lead to S/N independent of B0 even for spectroscopic
applications.
■ MATERIALS AND METHODS
Solutions of substrates in D2O/H2O were added to [IrCl(IDEG)-
(COD)] (IDEG = 1,3-bis(3,4,5-tris(diethyleneglycol)benzyl))-imida-
zole-2-ylidene), COD = 1,5-cyclooctadiene), stirred until a homoge-
neous solution of known concentration in catalyst is obtained, and
transferred to a 5 mm medium wall pressure NMR tube (Wilmad 524-
PV-7). The typical sample volume was 350 μL. The solution was
bubbled with argon for 30 min and pressurized with 10 bar of para-H2,
and hydrogen ﬂow was adjusted to obtain adequate bubbling. Catalyst
activation times were 0.25−12 h depending on substrate, solvent
(deuterated solvents require longer activation times), and temperature.
Catalyst activation can be sped up signiﬁcantly by raising the
temperature. For SABRE-SHEATH experiments para-H2 (Bruker
BPHG 090, 38 K, 90%) was bubbled through a sample placed in a μT
magnetic ﬁeld. Hyperpolarization buildup is achieved in 0.5−2 min.
The μT ﬁeld is generated by a small solenoid inside a magnetic shield
(see Scheme 1). The sample temperature was controlled with a water
bath inside the magnetic shields. Measurements were performed with a
Bruker Avance DX 360 (8.45 T) or Magritek Spinsolve 1H/15N
spectrometer (1 T). Enhancements are calculated relative to neat 15N-
labeled pyridine. The concentration in the samples was monitored by
1H spectroscopy.
■ CONCLUSIONS
We have demonstrated SABRE-SHEATH hyperpolarization of
15N in aqueous media at moderate temperatures (20−80 °C)
and achieve up to 1000-fold enhancements over thermal
measurements at 8.45 T. We applied SABRE-SHEATH in
water to biocompatible marker groups in diﬀerent molecules
(CHCA, nicotinamide, diazirine moieties). Hyperpolarization
of 15N-nitrile and the 15N2-diazirine exempliﬁes how SABRE-
SHEATH is amenable to more substrate classes because 15N is
closer to the hyperpolarization source than protons in the
molecular backbone.
Furthermore, we demonstrated T1 times comparable to, or
exceeding, clinically used DNP tracers.9,10 For example,
nicotinamide in D2O exhibits a
15N relaxation time of 2 min,
which is signiﬁcantly longer than typical 1H-T1 (seconds) of
traditional 1H-SABRE substrates. Still, recent advances have
demonstrated long-lived 1H singlet states with decay times of
up to 4.5 min.37 When such strategies are translated to 15N,
lifetimes in excess of 20 min become available.60
Imaging applications of SABRE hyperpolarized protons25 as
well as nitrogen-15 have already been reported.43 Hyper-
polarized heteronuclei are beneﬁcial, as they are background
free and have a large chemical shift range, which allows for easy
chemical identiﬁcation. Future developments may be expected
to advance SABRE to in vivo molecular imaging complement-
ing DNP-hyperpolarized 13C tracers, which have quickly
become an essential and routine tool, giving detailed and
fundamental insight into in vivo metabolism and biochemis-
try.9,10,61−65
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